Evolent Health (NYSE:EVH) PT Lowered to $47.00 at Guggenheim

Evolent Health (NYSE:EVH – Free Report) had its target price cut by Guggenheim from $50.00 to $47.00 in a research note released on Monday, The Fly reports. Several other equities analysts have also recently weighed in on the company. StockNews.com assumed coverage on Evolent Health in a report on Thursday, May 18th. They set a […]

Related Keywords

United States ,Frankj Williams ,Daniel Joseph Mccarthy ,Evolent Health ,Evolent Health Company Profile ,Vanguard Group Inc ,Evolent Health Services ,Clinical Solutions ,Securities Exchange Commission ,Granahan Investment Management ,News Ratings For Evolent Health Daily ,Evolent Health Inc ,Blackrock Inc ,Evolent Health Trading ,Analyst Recommendations For Evolent Health ,Institutional Investors Weigh In On Evolent Health ,Free Report ,Moderate Buy ,Director Frank ,Exchange Commission ,President Daniel Joseph Mccarthy ,Investment Management ,Evolent Health Daily ,